Metaraminol Bitartrate

Metaraminol Bitartrate (CAS No.: 33402-03-8) is a synthetic sympathomimetic small molecule in the adrenergic modulator class that is broadly categorized as a predominately alpha adrenergic agonist and functional vasoconstrictive probe for cardiovascular and autonomic pharmacology research, with a biological activity profile characterized by dominant engagement of alpha 1 adrenergic receptor signaling and potential mixed direct and indirect adrenergic effects that can increase peripheral vascular tone in experimental systems; in mechanistic studies, its actions are typically interpreted through G protein coupled alpha adrenergic pathways involving Gq phospholipase C activation, inositol phosphate turnover, intracellular calcium mobilization, and downstream smooth muscle contractile responses, with context dependent contributions from norepinephrine handling and sympathetic nerve associated mechanisms in selected models; although publicly standardized potency datasets are limited across assay platforms, reported pharmacological behavior for this class is generally evaluated in the nanomolar to micromolar range depending on receptor expression, tissue preparation, and assay endpoint, and the compound is commonly applied as a reference agonist or comparator control in isolated vessel preparations, adrenergic receptor functional assays, hemodynamic physiology studies, and translational preclinical workflows focused on vascular reactivity, receptor pharmacodynamics, and mechanism based screening, while concentrations or doses used in experiments typically depend on specific experimental designs, species or cell background, route of administration, and research objectives.